Quest for the right Drug
נקסיום טבליות 40 מ"ג NEXIUM TABLETS 40 MG (ESOMEPRAZOLE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
פומי : PER OS
צורת מינון:
טבליה : TABLETS
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Posology : מינונים
4.2 Posology and method of administration The tablets should be swallowed whole with liquid. The tablets should not be chewed or crushed. For patients who have difficulty in swallowing, the tablets can also be dispersed in half a glass of non-carbonated water. No other liquids should be used as the enteric coating may be dissolved. Stir until the tablets disintegrate and drink the liquid with the pellets immediately or within 30 minutes. Rinse the glass with half a glass of water and drink. The pellets must not be chewed or crushed. For patients who cannot swallow, the tablets can be dispersed in non-carbonated water and administered through a gastric tube. It is important that the appropriateness of the selected syringe and tube is carefully tested. For preparation and administration instructions see section 6.6 Adults. Gastroesophageal Reflux Disease (GERD) - treatment of erosive reflux esophagitis 40 mg once daily for 4 weeks. An additional 4 weeks treatment is recommended for patients in whom esophagitis has not healed or who have persistent symptoms. - long-term management of patients with healed esophagitis to prevent relapse 20 mg once daily. - symptomatic treatment of gastroesophageal reflux disease (GERD) 20 mg once daily in patients without esophagitis. If symptom control has not been achieved after four weeks, the patient should be further investigated. Once symptoms have resolved, subsequent symptom control can be achieved using an on-demand regimen taking 20 mg once daily, when needed. In NSAID treated patients at risk of developing gastric and duodenal ulcers, subsequent symptom control using an on-demand regimen is not recommended. Adults In combination with an appropriate antibacterial therapeutic regimen for the eradication of Helicobacter pylori and - healing of Helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers. 20 mg NEXIUM with 1 g amoxicillin and 500 mg clarithromycin, all twice daily for 7 days. Patients requiring NSAID therapy - healing of gastric ulcers associated with NSAID therapy: The usual dose is 20 mg once daily. The treatment duration is 4-8 weeks. - prevention of gastric and duodenal ulcers associated with NSAID therapy in patients at risk: 20 mg once daily. Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers. 40 mg once daily for 4 weeks after i.v. induced prevention of rebleeding of peptic ulcers. Special Populations Impaired renal function Dose adjustment is not required in patients with impaired renal function. Due to limited experience in patients with severe renal insufficiency, such patients should be treated with caution (see section 5.2). Impaired hepatic function Dose adjustment is not required in patients with mild to moderate liver impairment. For patients with severe liver impairment, a maximum dose of 20 mg NEXIUM should not be exceeded (see section 5.2). Elderly Dose adjustment is not required in the elderly. Paediatric population Adolescents from the age of 12 years Gastroesophageal Reflux Disease (GERD) - treatment of erosive reflux esophagitis: 40 mg once daily for 4 weeks. An additional 4 weeks treatment is recommended for patients in whom esophagitis has not healed or who have persistent symptoms. - long-term management of patients with healed esophagitis to prevent relapse 20 mg once daily. - symptomatic treatment of gastroesophageal reflux disease (GERD) 20 mg once daily in patients without esophagitis. If symptom control has not been achieved after 4 weeks, the patient should be further investigated. Once symptoms have resolved, subsequent symptom control can be achieved using 20 mg once daily. Treatment of duodenal ulcer caused by Helicobacter pylori When selecting appropriate combination therapy, consideration should be given to official national, regional and local guidance regarding bacterial resistance, duration of treatment (most commonly 7 days but sometimes up to 14 days), and appropriate use of antibacterial agents. The treatment should be supervised by a specialist. The posology recommendation is:
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף
עלון מידע לצרכן
25.05.22 - עלון לצרכן אנגלית 25.05.22 - עלון לצרכן עברית 25.05.22 - עלון לצרכן ערבית 14.09.23 - עלון לצרכן עברית 22.09.23 - עלון לצרכן אנגלית 22.09.23 - עלון לצרכן ערבית 30.11.11 - החמרה לעלון 30.11.11 - החמרה לעלון 07.03.12 - החמרה לעלון 15.03.12 - החמרה לעלון 14.08.12 - החמרה לעלון 12.06.13 - החמרה לעלון 21.07.16 - החמרה לעלון 14.08.17 - החמרה לעלון 23.09.21 - החמרה לעלון 25.05.22 - החמרה לעלון 14.09.23 - החמרה לעלוןלתרופה במאגר משרד הבריאות
נקסיום טבליות 40 מ"ג